newsfilter
← Latest News
GlobeNewswire·

Recent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes Patients

WOBURN, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) noted the recent publication of two large studies that support the clinical utility of DPNCheck screening in people with diabetes. Ke